Conatus Pharmaceuticals - 6 Year Stock Split History | CNAT
Stock split history for Conatus Pharmaceuticals since 2013. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
|Conatus Pharmaceuticals Annual Stock Splits
|Conatus Pharmaceuticals Quarterly Stock Splits
||Medical Products Manufacturing
Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.